Fig. 1From: Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patientsA Study design and clinical outcomes. A Schematic overview of the study cohort and the methods description. B Alluvial plot showing the number of individuals crossing over the disease groups, gender, DAS28-CRP, DAS28-ESR, RA-related autoantibodies such as rheumatoid factor (RF), anti-citrullinated protein antibody (ACPA), anti-nuclear antibodies (ANA), and anti-keratin antibodies (AKA)Back to article page